journal article·2015-02

In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system

Su A Park, Sang Jin Lee, Kyung Seob Lim, In Ho Bae, Jun Hee Lee, Wan Doo Kim, Myung Ho Jeong, Jun-Kyu Park

Materials Letters· Volume 141
Publisher page

Abstract

In this study, we prepared a helical, biocompatible, and biodegradable stent by 3D rapid prototyping. The fabricated polycaprolactone (PCL) stent was coated with sirolimus mixed with poly-(lactide-co-glycolide) (PLGA), and polyethylene glycol (PEG), via a spraying method for slow drug release. The engineered, drug-eluting, bio-absorbable vascular stent (BVS) was analyzed and tested in vivo, and proving effective in animal experiments. These findings suggest that our new approach is useful for treating coronary thrombosis, and it may provide a promising scaffold for developing biological stent technology.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Coronary Interventions and Diagnostics · Electrospun Nanofibers in Biomedical Applications · Cardiac and Coronary Surgery Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application10.1161/01.CIR.30.5.654 ↗
2. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty10.1056/NEJM198703193161201 ↗
3. Mechanisms of controlled drug release from drug-eluting stents10.1016/j.addr.2006.01.016 ↗
4. Ormiston · JACC Cardiovasc Intervent · 2013 · 6 · 102610.1016/j.jcin.2013.05.013 ↗
5. Coronary stent thrombosis: current insights into new drug-eluting stent designs10.4068/cmj.2012.48.3.141 ↗
6. Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea10.1016/j.ijcard.2010.09.012 ↗
7. Very late stent thrombosis in a drug-eluting stent due to interruption of anti-platelet agents in patients with acute myocardial infarction and thrombocytosis10.4070/kcj.2011.41.7.417 ↗
8. Drug-eluting stent thrombosis during perioperative period10.1536/ihj.49.135 ↗
9. Fabrication of nano/microfiber scaffolds using a combination of rapid prototyping and electrospinning systems10.1002/pen.21982 ↗
10. Bioresorbable scaffolds: rationale, current status, challenges, and future